Drugs Made In America Acquisition Corp. Balance Sheet
Drugs Made In America Acquisition Corp.'s total assets for Q2 2026 were $146.90M, a decrease of -39.30% from the previous quarter. DMAA total liabilities were $9.14M for the fiscal quarter, a 23.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.